share_log

金城医药(300233.SZ):终端制剂产品磷酸奥司他韦可用于治疗或预防甲型、乙型流感

Shandong Jincheng Pharmaceutical Group (300233.SZ): The terminal formulation product Oseltamivir phosphate can be used to treat or prevent influenza A and B.

Gelonghui Finance ·  Jan 6 08:34

On January 6, 2023, Gelonghui reported that Shandong Jincheng Pharmaceutical Group (300233.SZ) stated on the investor interaction platform that the company produces and sells Oseltamivir phosphate Active Pharmaceutical Ingredient. Its terminal formulation product Oseltamivir phosphate can be used for the treatment or prevention of Influenza A and B.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment